Novavax | NVAX - Market Capitalization


Novavax reported $1.11B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
Agenus USD 3.19B 3.06B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
BioCryst Pharmaceuticals USD 1.9B 643M Aug/2026
Cassava Sciences USD 82M 14M Mar/2026
Geron USD 979M 24M Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
MannKind USD 1.11B 207M Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Novartis USD 288.26B 25.18B Mar/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 153.17B 14.73B Aug/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
TG Therapeutics USD 7.63B 778M Aug/2026